what tier are glp 1 drugs Mapping the effectiveness and risks of GLP-1 receptor agonists The Future of Weight Loss:

Interventions that support mitochondrial efficiency, stabilize nutrient sensing, and limit the accumulation of senescent cells may contribute to preserving physiological resilience, even if they do not directly alter the primary drivers of aging

Quianzon CCL, Shomal ME

That study found no increased risk of breast cancer among roughly 46,000 GLP1 treated patients with roughly 41,000 controls [47]

However, she called the osteoporosis finding an early signal, noting that I dont think its conclusive. Future research on GLP-1 medications should focus on the incidence of fractures, which bone density loss can increase risk of, she said

Schirra J, Houck P, Wank U, Arnold R, Goke B, Katschinski M

Key features of retatrutide include: Acts as a triple agonist on GLP-1, GIP, and glucagon